ALPS Advisors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

ALPS Advisors’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-26,532	Closed	-$884K	–	1049
2024 Q3	$884K	Buy	26,532 +293	+1%	+$10.1K	0.01%	530
2024 Q2	$709K	Buy	+26,239	New	+$517K	﹤0.01%	526

ALPS Advisors's LBPH Position: Q4 2024 in Review

ALPS Advisors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 26,532 shares — an estimated $884K sold.

ALPS Advisors first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $884K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

ALPS Advisors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
ALPS Advisors sold 26,532 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $884K.
ALPS Advisors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
ALPS Advisors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $884K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on ALPS Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.